thiophenes has been researched along with Dyspnea in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jover, E; Tello-Montoliu, A; Valdés, M | 1 |
| Caldeira, D; Ferreira, JJ; Pinto, FJ | 1 |
| Safdar, Z | 1 |
| Bonafede, M; Deitelzweig, SB; Gdovin Bergeson, J; Graham, J; Jing, Y; Liffmann, D; Makenbaeva, D | 1 |
| Hwang, LJ; Jardim, C; Jerjes-Sánchez Díaz, C; Kurzyna, M; Pulido, T; Ramírez, A; Sandoval, J; Souza, R; Teal, SA; Torbicki, A | 1 |
| Badesch, D; Barst, RJ; Frost, A; Galie, N; Langleben, D; Lawrence, EC; Naeije, R; Shapiro, S | 1 |
| Gutová, M; Hlousek, Z; Hlousková, Z | 1 |
| Klein, G; Urbanek, R | 1 |
| Aubier, M; Berdah, L | 1 |
| De Mey, J; Meysman, M; Neyns, B; Schallier, D | 1 |
| Göbel, P | 1 |
| Hlinka, V; Labus, J | 1 |
2 review(s) available for thiophenes and Dyspnea
| Article | Year |
|---|---|
[New antiplatelet drugs in coronary artery disease].
Topics: Adenosine; Adenosine Monophosphate; Clinical Trials, Phase III as Topic; Coronary Artery Disease; Double-Blind Method; Dyspnea; Hemorrhage; Humans; Multicenter Studies as Topic; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Receptors, Proteinase-Activated; Thiophenes; Ticagrelor; Treatment Outcome | 2014 |
Dyspnea and reversibility profile of P2Y₁₂ antagonists: systematic review of new antiplatelet drugs.
Topics: Adenosine; Adenosine Monophosphate; Clopidogrel; Dyspnea; Humans; Incidence; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Quinazolinones; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Sulfonamides; Thiophenes; Ticagrelor; Ticlopidine | 2014 |
6 trial(s) available for thiophenes and Dyspnea
| Article | Year |
|---|---|
Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension.
Topics: Adolescent; Adult; Aged; Blood Pressure; Child; Dose-Response Relationship, Drug; Double-Blind Method; Dyspnea; Endothelin Receptor Antagonists; Endpoint Determination; Female; Humans; Hypertension, Pulmonary; Intention to Treat Analysis; Isoxazoles; Kaplan-Meier Estimate; Liver Function Tests; Male; Middle Aged; Pulmonary Wedge Pressure; Sample Size; Thiophenes; Treatment Outcome; Vascular Resistance; Young Adult | 2012 |
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Bosentan; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Dyspnea; Endothelin A Receptor Antagonists; Exercise Test; Exercise Tolerance; Female; Health Status Indicators; Hemodynamics; Humans; Hypertension, Pulmonary; Isoxazoles; Male; Middle Aged; Risk Assessment; Sulfonamides; Thiophenes; Treatment Outcome | 2006 |
A comparison between the efficacy of ketotifen and clemastine in children.
Topics: Asthma; Child; Child, Preschool; Clemastine; Dyspnea; Female; Histamine H1 Antagonists; Humans; Infant; Ketotifen; Male; Piperidines; Pyrrolidines; Thiophenes | 1980 |
[Multicenter, controlled, double-blind study of the efficacy and tolerance of Vectrine (erdostein) versus placebo in the treatment of stabilized chronic bronchitis with hypersecretion].
Topics: Administration, Oral; Adult; Aged; Bronchitis; Chronic Disease; Double-Blind Method; Dyspnea; Expectorants; Female; Humans; Male; Middle Aged; Severity of Illness Index; Thioglycolates; Thiophenes; Treatment Outcome | 1999 |
The protective effect of ketotifen in bronchial asthma.
Topics: Adolescent; Adult; Asthma; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Dyspnea; Female; Forced Expiratory Flow Rates; Histamine H1 Antagonists; Humans; Male; Middle Aged; Mucus; Piperidines; Thiophenes; Vital Capacity | 1978 |
The clinical effect of ketotifen in bronchial asthma.
Topics: Adult; Asthma; Carbon Dioxide; Clinical Trials as Topic; Dyspnea; Female; Humans; Lung; Male; Middle Aged; Oxygen; Piperidines; Respiratory Function Tests; Spirometry; Thiophenes; Time Factors | 1979 |
4 other study(ies) available for thiophenes and Dyspnea
| Article | Year |
|---|---|
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Drug Substitution; Dyspnea; Edema; Endothelin A Receptor Antagonists; Exercise Test; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Isoxazoles; Liver Function Tests; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen; Phenylpropionates; Pyridazines; Retrospective Studies; Texas; Thiophenes; Time Factors; Treatment Outcome; Walking | 2011 |
Impact of dyspnea on medical utilization and affiliated costs in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Costs and Cost Analysis; Diagnostic Techniques and Procedures; Drug Therapy, Combination; Dyspnea; Emergency Service, Hospital; Female; Humans; Insurance Claim Review; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Ticlopidine | 2011 |
[Protective effect of ketotifen, investigations in allergic children with bronchial asthma (author's transl)].
Topics: Administration, Topical; Adolescent; Asthma; Bronchodilator Agents; Child; Child, Preschool; Cough; Dyspnea; Humans; Ketotifen; Piperidines; Steroids; Thiophenes | 1980 |
Raltitrexed-related pulmonary toxicity.
Topics: Aged; Antimetabolites, Antineoplastic; Colonic Neoplasms; Dyspnea; Female; Humans; Lung Diseases; Quinazolines; Radiography, Thoracic; Thiophenes | 2000 |